Source: MarketScreener

Trilink Biotech: TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product

(marketscreener.com) TriLink now offers GMP-grade N1-Methyl-Pseudouridine-5'-Triphosphate, a critical raw material for mRNA manufacturing, allowing researchers to accelerate their drug discovery and development timelines and US-source their supply chainSAN DIEGO, Sept. 13, 2022 -- TriLink BioTechnologies , a Maravai LifeSciences company and global provider...https://www.marketscreener.com/quote/stock/MARAVAI-LIFESCIENCES-HOLD-115395180/news/TriLink-BioTechnologies-Part-of-Maravai-LifeSciences-Expands-its-mRNA-Raw-Material-Offering-with-t-41761572/?utm_medium=RSS&utm_content=20220913

Read full article »
Est. Annual Revenue
<$1M
Agree?
Est. Employees
100-250
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Trilink Biotech's headquarters is located in San Diego, California.